Robert Holloway, MD, presents a patient case of metastatic endometrial cancer and discusses the systemic therapy options and recommended guidelines in this setting.
EP. 1: Case Overview: A 71-Year-Old Woman with Metastatic Endometrial Cancer
Robert Holloway, MD, presents the diagnosis and treatment regimen of a 71-year-old woman with mismatch repair-proficient (pMMR) metastatic endometrial cancer.
EP. 2: Presentation of Endometrial Cancer and MMR Testing
Dr Robert Holloway describes the presentation of a typical patient with metastatic endometrial cancer, and whether all patients receive MMR testing.
EP. 3: Available Systemic Therapy Options for Patients with MMR-Proficient Metastatic Endometrial Cancer
An expert details the currently available systemic therapies for patients with MMR-proficient metastatic endometrial cancer who experienced recurrent disease after platinum-based chemotherapy.
EP. 4: KEYNOTE-775: Lenvatinib/Pembrolizumab in Patients with Advanced Endometrial Carcinoma
Robert Holloway, MD, review safety and efficacy data from a clinical trial investigation of lenvatinib combined with pembrolizumab for the treatment of advanced endometrial cancer.
EP. 5: Selecting an Appropriate Second-Line Treatment for Metastatic Endometrial Cancer
Dr Robert Holloway explains what second-line treatment regimen he would have chosen for the patient with metastatic endometrial cancer in the presented case.
EP. 6: Second-Line Treatment Goals and Adverse Event Management for Patients with Metastatic Endometrial Cancer
Insights into the goals of second-line therapy for patients with advanced/recurrent endometrial carcinoma, and best strategies for adverse event management.
EP. 7: Racial Disparities and Unmet Needs in Endometrial Cancer
Robert Holloway, MD, highlights the issue of racial disparity in endometrial cancer, and the critical unmet needs for patients.
2 Clarke Drive Cranbury, NJ 08512